| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.19 | 0.001 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.096 | 0.003 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.16 | 0.004 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.005 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.16 | 0.005 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.005 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.097 | 0.007 |